Description

Maternal gut microbiota composition at enrollment is compared between the FOS and placebo groups, establishing the starting point for evaluating prebiotic effects during pregnancy.

Figure 2

Chart

Source Paper

Maternal Prebiotic Ingestion Increased the Number of Fecal Bifidobacteria in Pregnant Women but Not in Their Neonates Aged One Month.

Nutrients (2017)

PMID: 28245628

DOI: 10.3390/nu9030196

Cite This Figure

![Figure 2: Maternal gut microbiota composition at enrollment is compared between the FOS and placebo groups, establishing the starting point for evaluating prebiotic effects during pregnancy.]()

> Source: Shinji Jinno et al. "Maternal Prebiotic Ingestion Increased the Number of Fecal Bifidobacteria in Pre." *Nutrients*, 2017. PMID: [28245628](https://pubmed.ncbi.nlm.nih.gov/28245628/)

<figure>
  <img src="" alt="Maternal gut microbiota composition at enrollment is compared between the FOS and placebo groups, establishing the starting point for evaluating prebiotic effects during pregnancy." />
  <figcaption>Figure 2. Maternal gut microbiota composition at enrollment is compared between the FOS and placebo groups, establishing the starting point for evaluating prebiotic effects during pregnancy.<br>  Source: Shinji Jinno et al. "Maternal Prebiotic Ingestion Increased the Number of Fecal Bifidobacteria in Pre." <em>Nutrients</em>, 2017. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/28245628/">28245628</a></figcaption>
</figure>

Related Evidence

Fructooligosaccharides (FOS) for Chronic Constipation

Grade C · 4 studies